Molecular detection is currently a part of clinical oncology diagnostics. The recent grow of advanced molecular technologies enables for a certain number of cases to optimize the treatment by incorporating individual, molecular DNA-characteristics of the tumor and of the patient himself: the so-called ‘Targeted Next-Generation-Sequencing (NGS).
The introduction of NGS in molecular oncology diagnostics requires a profound preparatory phase, both in the field and on policy level. A feasibility study, performed by the Cancer center (WIV-ISP) and the KCE, resulted in a roadbook ‘Personalized medicin’ – Introduction of ‘Next-Generation-Sequencing’ in routine oncology and hemato-oncology diagnostics.
This road book contains 10 action points. The current request relates to action point 6: NGS data registration, storage and management.
|Release Date|| |
|Public Access Level|| |